Rubicon Biotechnology LLC

Website
15375 Barranca Pkwy Ste B104
Irvine, CA 92618

Rubicon Biotechnology LLC, based in Irvine, CA, is dedicated to developing novel targeted therapies aimed at significantly benefiting patient outcomes in trauma and cancer care. The company is innovating two leading-edge platform technologies: Fv-Hsp72, designed as a targeted cytoprotectant for acute indications, and Modified Annexin, focused on cancer treatment through specific targeting of tumor environments.

Fv-Hsp72 seeks to mitigate cellular damage during myocardial infarction and other acute conditions, while the Modified Annexin program utilizes a unique adaptation of a natural protein to deliver anti-cancer compounds directly to solid tumors and their associated vasculature. With a seasoned executive team and strategic collaborations, Rubicon is well-positioned to advance its pioneering therapies.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesCaliforniaIrvineRubicon Biotechnology LLC

Partial Data by Infogroup (c) 2024. All rights reserved.